Home

Market Capitalization of Alivus Life Sciences Ltd

Image

Alivus Life Sciences Ltd

NSE: ALIVUS

Market Cap

₹ 14892.64 crore

Last updated on: Feb 04, 2025

Key Highlights

  • The Market Cap of Alivus Life Sciences Ltd is ₹ 14892 crore as of 04 Feb 25 .
  • The Latest Trading Price of Alivus Life Sciences Ltd is ₹ 1223 as of 05 Feb 13:01 .
  • The Dividend Payouts of Alivus Life Sciences Ltd changed from ₹ 10.5 on Nov 22, 2021 to ₹ 22.5 on Oct 17, 2023 . This represents a CAGR of 20.99% over 4 years.
Image

Alivus Life Sciences Ltd

NSE: ALIVUS

Share Price

₹ 1223.85

8.45 (0.70%)

stock direction

Last updated on: Feb 05, 2025

Market Price of Alivus Life Sciences Ltd

1M

1Y

3Y

5Y

Monitoring Alivus Life Sciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
04 Feb 20251215.4
03 Feb 20251175.05
01 Feb 20251154.6
31 Jan 20251202
30 Jan 20251168.3
29 Jan 20251158.4
28 Jan 20251156.85
27 Jan 20251197.35
24 Jan 20251151.35
23 Jan 20251173.3

SWOT Analysis Of Alivus Life Sciences Ltd

Strength

2

che

Weakness

2

che

Opportunity

1

che

Threats

0

che

BlinkX Score for Alivus Life Sciences Ltd

Asset Value vs Market Value of Alivus Life Sciences Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of Market Cap

Key Valuation Metric of Alivus Life Sciences Ltd

No data available

No data available

Historical P/E Ratio of Alivus Life Sciences Ltd

No data available

* All values are in %

Historical Revenue of Alivus Life Sciences Ltd

No data available

* All values are in crore

Historical EBITDA of Alivus Life Sciences Ltd

No data available

* All values are in crore

Historical Net Profit of Alivus Life Sciences Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Alivus Life Sciences Ltd

No data available

* All values are in

About Alivus Life Sciences Ltd

  • Glenmark Life Sciences Limited was incorporated as Zorg Laboratories Private Limited', on June 23, 2011 at Pune and was granted the Certificate of Incorporation by the Registrar of Companies, Maharashtra at Pune.
  • Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited through a Share Purchase Agreement dated 04 July 2018 and the name of the Company was changed to Glenmark Life Sciences Private Limited' dated 10 August 2018.
  • A shareholders' resolution was passed on 13 August 2018 to convert the Company from a Private Limited Company to a Public Limited Company and a fresh Certificate of Incorporation dated 28 August 2018 was issued by the RoC. The Company is a wholly owned Subsidiary of Glenmark Pharmaceuticals Limited.
  • The Company acquired API Division of Glenmark Pharmaceuticals Limited (the parent company) on 01 January, 2019.

Alivus Life Sciences Ltd News Hub

Glenmark Life Sciences Ltd leads gainers in 'A' group

Tamilnad Mercantile Bank Ltd, Marico Ltd, Rossari Biotech Ltd and Nestle India Ltd are among the oth

Read more

05 Aug 24

Glenmark Life Sciences AGM scheduled

Glenmark Life Sciences announced that the Annual General Meeting (AGM) of the company will be held o

Read more

06 Sept 24

Glenmark Life drops after PAT slides 20% YoY to Rs 95 crore in Q2

Profit before tax (PBT) dropped 19.8% YoY to Rs 127.46 crore in the quarter ended 30 September 2024.

Read more

25 Oct 24

Glenmark Life Sciences standalone net profit declines 19.72% in the September 2024 quarter

Net profit of Glenmark Life Sciences declined 19.72% to Rs 95.32 crore in the quarter ended Septembe

Read more

25 Oct 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Alivus Life Sciences Ltd Market Cap

What is the market cap of Alivus Life Sciences Ltd?

As of February 5, 2025, Alivus Life Sciences Ltd has a market capitalization of ₹14892.64, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Alivus Life Sciences Ltd's market capitalization?

Alivus Life Sciences Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Alivus Life Sciences Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Alivus Life Sciences Ltd's market capitalization change?

Alivus Life Sciences Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions